Next 10 |
2024-05-15 14:15:34 ET Inovio Pharmaceuticals, Inc. (INO) RBC Capital Markets Global Healthcare Conference May 15, 2024 10:00 AM ET Company Participants Jacqueline Shea - CEO Mike Sumner - Chief Medical Officer Conference Call Participants Gregory Renza -...
2024-05-14 16:44:07 ET Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference May 14, 2024, 11:30 AM ET Company Participants Jacqueline Shea - CEO Conference Call Participants Roy Buchanan - Citizens JMP Presentation Roy Bu...
2024-05-13 21:45:14 ET Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q1 2024 Earnings Call May 13, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call ...
2024-05-13 19:47:09 ET Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Conference Call May 13, 2024, 04:30 PM ET Company Participants Thomas Hong - Manager of Investor Relations Jacqueline Shea - President and Chief Executive Officer Michael Sumner - Chief Me...
2024-05-13 18:00:04 ET Sudan Loganathan from Stephens issued a price target of $20.00 for INO on 2024-05-13 16:32:00. The adjusted price target was set to $20.00. At the time of the announcement, INO was trading at $11.36. The overall price target consensus is at $4.00 w...
2024-05-13 16:07:13 ET More on Inovio Pharmaceuticals Inovio Pharmaceuticals: Neutral On INO-3107 Amidst Stock Dilution And High Valuation Inovio Pharmaceuticals: The Dilution Continues Inovio Pharmaceuticals, Inc. (INO) Q4 2023 Earnings Call Transcript Inovi...
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights PR Newswire BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgical treatment for recurrent respiratory papilloma...
Aileron Therapeutics Inc. (ALRN) is expected to report for Q1 2024 DZS Inc. (DZSI) is expected to report $-0.09 for Q1 2024 Bitfarms Ltd. (BITF) is expected to report $-0.03 for Q1 2024 180 Degree Capital Corp. (TURN) is expected to report for quarter end 2024-03-31 Abacus Life In...
Q1 2024 revenue of $45.0 million Q1 2024 GAAP Net Loss of $4.5 million and positive Adjusted EBITDA of $3.8 million Fifth consecutive quarter of positive Adjusted EBITDA Inseego Corp. (Nasdaq: INSG) (the “Company”), a technology leader in 5G mobile and ...
2024-05-05 08:54:00 ET Some investors might remember Inovio Pharmaceuticals (NASDAQ: INO) ; others might not. The small-cap biotech was once racing to develop an effective coronavirus vaccine. Its bet to become a leader in this field fell flat, the company largely fell into irreleva...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
Stephens initiated coverage on INOVIO Pharmaceuticals Inc (NASDAQ:INO), noting the company’s diversified clinical pipeline of ...
2024-05-13 21:45:14 ET Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q1 2024 Earnings Call May 13, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call ...
2024-05-13 18:00:04 ET Sudan Loganathan from Stephens issued a price target of $20.00 for INO on 2024-05-13 16:32:00. The adjusted price target was set to $20.00. At the time of the announcement, INO was trading at $11.36. The overall price target consensus is at $4.00 w...